Evidence map›Paper›PMID 41155463›Full record

ArticleInternational journal of molecular sciences2025

DD-CC-II: Data Driven Cell-Cell Interaction Inference and Its Application to COVID-19.

Heewon Park, Satoru Miyano

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Heewon ParkSchool of Mathematics Statistics and Data Science, Sungshin Women's University, Seoul 01133, Republic of Korea.
Satoru MiyanoM&D Data Science Center, Institute of Science Tokyo, Tokyo 113-8510, Japan.ORCID 0000-0002-1753-6616

Funding

Japan Agency for Medical Research and Development 23tk0124003h0001, 24tk0124003h0002, and 470 25tk0124003h0003Japan society for the promotion of science JP24H00009National research foundation RS-2023-00276559
6 · The paper itself

Abstract

Cell-cell interactions play a pivotal role in maintaining tissue homeostasis and driving disease progression. Conventional Cell-cell interactions modeling approaches depend on ligand-receptor databases, which often fail to capture context-specific or newly emerging signaling mechanisms. To address this limitation, we propose a data-driven computational framework, data-driven cell-cell interaction inference (DD-CC-II), which employs a graph-based model using eigen-cells to represent cell groups. DD-CC-II uses eigen-cells (i.e., functional module within the cell population) to characterize cell groups and construct correlation coefficient networks to model between-group associations. Correlation coefficient networks between eigen-cells are constructed, and their statistical significance is evaluated via over-representation analysis and hypergeometric testing. Monte Carlo simulations demonstrate that DD-CC-II achieves superior performance in inferring CCIs compared with ligand-receptor-based methods. The application to whole-blood RNA-seq data from the Japan COVID-19 Task Force revealed severity stage-specific interaction patterns. Markers such as FOS, CXCL8, and HLA-A were associated with high severity, whereas IL1B, CD3D, and CCL5 were related to low severity. The systemic lupus erythematosus pathway emerged as a potential immune mechanism underlying disease severity. Overall, DD-CC-II provides a data-centric approach for mapping the cellular communication landscape, facilitating a better understanding of disease progression at the intercellular level.

Indexed as

Cell CommunicationComputational BiologyCOVID-19HumansMonte Carlo MethodSARS-CoV-2cell–cell interactionsCOVID-19 severity stagedisease progression of COVID-19eigen-cellover-representation analysis

Identifiers

PMID41155463
PMCPMC12562397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.